"Sodium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An element that is a member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. With a valence of 1, it has a strong affinity for oxygen and other nonmetallic elements. Sodium provides the chief cation of the extracellular body fluids. Its salts are the most widely used in medicine. (From Dorland, 27th ed) Physiologically the sodium ion plays a major role in blood pressure regulation, maintenance of fluid volume, and electrolyte balance.
MeSH Number(s)
D01.268.549.750
D01.552.528.850
Below are MeSH descriptors whose meaning is more general than "Sodium".
Below are MeSH descriptors whose meaning is more specific than "Sodium".
This graph shows the total number of publications written about "Sodium" by people in Harvard Catalyst Profiles by year, and whether "Sodium" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 9 | 11 | 20 |
| 1994 | 5 | 11 | 16 |
| 1995 | 6 | 14 | 20 |
| 1996 | 7 | 12 | 19 |
| 1997 | 9 | 12 | 21 |
| 1998 | 7 | 8 | 15 |
| 1999 | 4 | 10 | 14 |
| 2000 | 2 | 4 | 6 |
| 2001 | 4 | 11 | 15 |
| 2002 | 8 | 12 | 20 |
| 2003 | 7 | 19 | 26 |
| 2004 | 3 | 17 | 20 |
| 2005 | 4 | 8 | 12 |
| 2006 | 6 | 14 | 20 |
| 2007 | 4 | 8 | 12 |
| 2008 | 3 | 12 | 15 |
| 2009 | 7 | 12 | 19 |
| 2010 | 8 | 17 | 25 |
| 2011 | 9 | 11 | 20 |
| 2012 | 6 | 16 | 22 |
| 2013 | 4 | 16 | 20 |
| 2014 | 11 | 9 | 20 |
| 2015 | 7 | 11 | 18 |
| 2016 | 9 | 12 | 21 |
| 2017 | 5 | 12 | 17 |
| 2018 | 15 | 12 | 27 |
| 2019 | 12 | 11 | 23 |
| 2020 | 7 | 17 | 24 |
| 2021 | 8 | 19 | 27 |
| 2022 | 4 | 64 | 68 |
| 2023 | 2 | 6 | 8 |
Below are the most recent publications written about "Sodium" by people in Profiles.
-
Potassium: To Add or to Replace…That Is the Question. Hypertension. 2023 May; 80(5):966-968.
-
Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis. Eur J Endocrinol. 2023 Mar 02; 188(3).
-
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer. Heart. 2023 02 23; 109(6):470-477.
-
Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs. Cell Metab. 2023 02 07; 35(2):299-315.e8.
-
Serum sodium, cognition and incident dementia in the general population. Age Ageing. 2023 02 01; 52(2).
-
Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH-Sodium Trial. J Am Heart Assoc. 2023 01 17; 12(2):e026684.
-
Renin-angiotensin-aldosterone system function in the pig-to-baboon kidney xenotransplantation model. Am J Transplant. 2023 03; 23(3):353-365.
-
Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US. JAMA Cardiol. 2023 01 01; 8(1):66-73.
-
Canagliflozin Improves Myocardial Perfusion, Fibrosis, and Function in a Swine Model of Chronic Myocardial Ischemia. J Am Heart Assoc. 2023 01 03; 12(1):e028623.
-
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozin. Diabetes Obes Metab. 2023 03; 25(3):758-766.